vs
Side-by-side financial comparison of Opus Genetics, Inc. (IRD) and VirTra, Inc (VTSI). Click either name above to swap in a different company.
Opus Genetics, Inc. is the larger business by last-quarter revenue ($3.9M vs $2.9M, roughly 1.3× VirTra, Inc). On growth, Opus Genetics, Inc. posted the faster year-over-year revenue change (-10.2% vs -46.5%). Over the past eight quarters, Opus Genetics, Inc.'s revenue compounded faster (50.3% CAGR vs -37.0%).
Opus Genetics, Inc. is a clinical-stage biotechnology company specializing in the development of targeted gene therapies for inherited retinal diseases. It focuses on addressing unmet medical needs for patients living with rare, vision-threatening ocular conditions, with operations centered on advancing accessible therapeutic candidates for global rare disease patient populations.
VirTra, Inc. is a global provider of highly realistic immersive training simulators and supporting curriculum, primarily serving law enforcement agencies, military units, and public safety organizations. Its scenario-based training systems are designed to enhance frontline personnel's decision-making, de-escalation skills, and on-duty operational safety.
IRD vs VTSI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $3.9M | $2.9M |
| Net Profit | — | $-792.4K |
| Gross Margin | — | 57.5% |
| Operating Margin | — | -47.9% |
| Net Margin | — | -27.2% |
| Revenue YoY | -10.2% | -46.5% |
| Net Profit YoY | 53.0% | 10.8% |
| EPS (diluted) | — | $-0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $3.9M | $2.9M | ||
| Q3 25 | $3.1M | $5.3M | ||
| Q2 25 | $2.9M | $7.0M | ||
| Q1 25 | $4.4M | $7.2M | ||
| Q4 24 | $4.3M | $5.4M | ||
| Q3 24 | $3.9M | $7.5M | ||
| Q2 24 | $1.1M | $6.1M | ||
| Q1 24 | $1.7M | $7.3M |
| Q4 25 | — | $-792.4K | ||
| Q3 25 | $-17.5M | $-388.6K | ||
| Q2 25 | $-7.4M | $175.3K | ||
| Q1 25 | $-8.2M | $1.3M | ||
| Q4 24 | — | $-888.3K | ||
| Q3 24 | $-7.5M | $583.1K | ||
| Q2 24 | $-7.8M | $1.2M | ||
| Q1 24 | $-7.1M | $468.2K |
| Q4 25 | — | 57.5% | ||
| Q3 25 | — | 65.8% | ||
| Q2 25 | — | 69.0% | ||
| Q1 25 | — | 72.6% | ||
| Q4 24 | — | 67.5% | ||
| Q3 24 | — | 73.5% | ||
| Q2 24 | — | 90.9% | ||
| Q1 24 | — | 64.2% |
| Q4 25 | — | -47.9% | ||
| Q3 25 | -269.9% | -8.4% | ||
| Q2 25 | -309.0% | 13.1% | ||
| Q1 25 | -227.2% | 19.1% | ||
| Q4 24 | — | -9.9% | ||
| Q3 24 | -207.1% | 10.1% | ||
| Q2 24 | -748.9% | 18.6% | ||
| Q1 24 | -450.5% | 8.9% |
| Q4 25 | — | -27.2% | ||
| Q3 25 | -566.9% | -7.3% | ||
| Q2 25 | -257.5% | 2.5% | ||
| Q1 25 | -187.5% | 17.7% | ||
| Q4 24 | — | -16.3% | ||
| Q3 24 | -194.6% | 7.8% | ||
| Q2 24 | -698.3% | 19.8% | ||
| Q1 24 | -415.3% | 6.4% |
| Q4 25 | — | $-0.08 | ||
| Q3 25 | $-0.25 | $-0.03 | ||
| Q2 25 | $-0.12 | $0.02 | ||
| Q1 25 | $-0.24 | $0.11 | ||
| Q4 24 | — | $-0.08 | ||
| Q3 24 | $-0.29 | $0.05 | ||
| Q2 24 | $-0.30 | $0.11 | ||
| Q1 24 | $-0.29 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $45.1M | $18.6M |
| Total DebtLower is stronger | — | $7.5M |
| Stockholders' EquityBook value | $15.3M | $45.6M |
| Total Assets | $50.2M | $65.1M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.1M | $18.6M | ||
| Q3 25 | $30.8M | $20.8M | ||
| Q2 25 | $32.4M | $20.7M | ||
| Q1 25 | $41.8M | $17.6M | ||
| Q4 24 | $30.3M | $18.0M | ||
| Q3 24 | $36.6M | $19.7M | ||
| Q2 24 | $41.4M | $18.4M | ||
| Q1 24 | $47.2M | $22.4M |
| Q4 25 | — | $7.5M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $7.8M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $15.3M | $45.6M | ||
| Q3 25 | $6.0M | $46.3M | ||
| Q2 25 | $17.5M | $46.8M | ||
| Q1 25 | $5.1M | $46.5M | ||
| Q4 24 | $6.7M | $45.2M | ||
| Q3 24 | $34.3M | $45.7M | ||
| Q2 24 | $40.6M | $44.9M | ||
| Q1 24 | $46.1M | $43.5M |
| Q4 25 | $50.2M | $65.1M | ||
| Q3 25 | $36.1M | $66.2M | ||
| Q2 25 | $38.7M | $67.4M | ||
| Q1 25 | $48.2M | $66.8M | ||
| Q4 24 | $36.9M | $65.0M | ||
| Q3 24 | $40.4M | $66.1M | ||
| Q2 24 | $44.8M | $66.0M | ||
| Q1 24 | $51.8M | $69.4M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.17× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-35.3M | $-1.5M |
| Free Cash FlowOCF − Capex | — | $-2.1M |
| FCF MarginFCF / Revenue | — | -72.5% |
| Capex IntensityCapex / Revenue | — | 21.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $2.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-35.3M | $-1.5M | ||
| Q3 25 | $-6.2M | $36.3K | ||
| Q2 25 | $-10.3M | $6.0M | ||
| Q1 25 | $-9.0M | $65.7K | ||
| Q4 24 | $-25.6M | $-908.7K | ||
| Q3 24 | $-5.1M | $897.7K | ||
| Q2 24 | $-7.3M | $-3.9M | ||
| Q1 24 | $-5.7M | $5.1M |
| Q4 25 | — | $-2.1M | ||
| Q3 25 | — | $-61.2K | ||
| Q2 25 | — | $5.4M | ||
| Q1 25 | — | $-362.7K | ||
| Q4 24 | — | $-1.1M | ||
| Q3 24 | — | $814.2K | ||
| Q2 24 | — | $-3.9M | ||
| Q1 24 | — | $3.6M |
| Q4 25 | — | -72.5% | ||
| Q3 25 | — | -1.1% | ||
| Q2 25 | — | 77.6% | ||
| Q1 25 | — | -5.1% | ||
| Q4 24 | — | -19.5% | ||
| Q3 24 | — | 10.9% | ||
| Q2 24 | — | -64.7% | ||
| Q1 24 | — | 48.9% |
| Q4 25 | — | 21.2% | ||
| Q3 25 | — | 1.8% | ||
| Q2 25 | — | 8.1% | ||
| Q1 25 | — | 6.0% | ||
| Q4 24 | — | 2.8% | ||
| Q3 24 | — | 1.1% | ||
| Q2 24 | — | 1.0% | ||
| Q1 24 | — | 21.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 34.12× | ||
| Q1 25 | — | 0.05× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.54× | ||
| Q2 24 | — | -3.22× | ||
| Q1 24 | — | 10.97× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
